| Literature DB >> 31590639 |
Kan Sun1, Diaozhu Lin1, Feng Qiling1, Feng Li1, Yiqin Qi1, Wanting Feng1, Meng Ren1, Li Yan2, Dan Liu3.
Abstract
BACKGROUND: Women with a higher number of pregnancies have a higher risk of developing cardiovascular diseases. Subtle fluctuations in albumin excretion could be related to pathophysiologic changes in the vascular system. We aimed to investigate the possible association of parity with low-grade albuminuria.Entities:
Keywords: Cardiovascular diseases; Low-grade albuminuria; Parity; Population-based study
Mesh:
Year: 2019 PMID: 31590639 PMCID: PMC6781324 DOI: 10.1186/s12905-019-0814-2
Source DB: PubMed Journal: BMC Womens Health ISSN: 1472-6874 Impact factor: 2.809
General characteristics of the study population
| Participants without low-grade albuminuria | Participants with low-grade albuminuria | ||
|---|---|---|---|
| n (%) | 4871 (75.0) | 1624 (25.0) | |
| Urinary ACR (mg/g) | 7.0 (5.4–8.8) | 15.1 (13.0–19.4) | < 0.0001 |
| Age (years) | 54.7 ± 7.4 | 56.1 ± 8.1 | < 0.0001 |
| BMI (kg/m2) | 23.4 ± 3.2 | 24.0 ± 3.9 | < 0.0001 |
| WC (cm) | 79.8 ± 8.9 | 81.2 ± 9.5 | < 0.0001 |
| SBP (mmHg) | 123.0 ± 15.4 | 128.1 ± 16.8 | < 0.0001 |
| DBP (mmHg) | 73.6 ± 9.1 | 75.4 ± 10.2 | < 0.0001 |
| Current smoking [n (%)] | 55 (1.2) | 23 (1.5) | 0.353 |
| Current drinking [n (%)] | 58 (1.2) | 23 (1.5) | 0.478 |
| TG (mmol/L) | 1.20 (0.88–1.69) | 1.30 (0.92–1.91) | < 0.0001 |
| TC (mmol/L) | 5.23 ± 1.26 | 5.34 ± 1.27 | 0.0003 |
| HDL-C (mmol/L) | 1.38 ± 0.37 | 1.37 ± 0.36 | 0.223 |
| LDL-C (mmol/L) | 3.16 ± 0.97 | 3.20 ± 0.99 | 0.106 |
| FPG (mmol/L) | 5.36 (4.97–5.82) | 5.45 (5.02–5.97) | < 0.0001 |
| Fasting insulin (μIU/ml) | 7.10 (5.30–9.80) | 7.80 (5.50–10.80) | < 0.0001 |
| γ-GGT (U/L) | 17.0 (13.0–24.0) | 19.0 (14.0–27.0) | < 0.0001 |
| eGFR (ml/min per 1.73 m2) | 104.3 ± 22.5 | 104.7 ± 24.2 | 0.590 |
| Physical activity (MET-h/week) | 22.0 (10.5–45.0) | 21.0 (10.5–42.0) | 0.092 |
| Prior history of CVD [n (%)] | 139 (2.9) | 46 (2.8) | 0.965 |
| High school or higher education [n (%)] | 2892 (61.4) | 912 (58.4) | 0.017 |
| Spontaneous abortion [n (%)] | 330 (6.8) | 92 (5.7) | 0.116 |
| Menopause [n (%)] | 1160 (25.2) | 333 (21.7) | 0.005 |
1. Data were means ± SD or medians (interquartile ranges) for skewed variables or numbers (proportions) for categorical variables; P-values were for the ANOVA or χ2 analyses between the two groups
2. ACR albumin to creatinine ratio, BMI body mass index, WC waist circumference, SBP systolic blood pressure, DBP diastolic blood pressure, TG triglycerides, TC total cholesterol, HDL-C high-density lipoprotein cholesterol, LDL-C low-density lipoprotein cholesterol, FPG fasting plasma glucose, eGFR estimated glomerular filtration rate, γ-GGT γ-glutamyltransferase, CVD cardiovascular diseases
Characteristics of study population by number of parity category
| Number of Parity | ||||
|---|---|---|---|---|
| 0 | 1 | 2 | ≥ 3 | |
| n (%) | 820 (12.6) | 4236 (65.2) | 981 (15.1) | 458 (7.1) |
| Urinary ACR (mg/g) | 8.0 (5.8–11.5) | 8.0 (5.8–11.2) | 8.6 (6.3–11.9) #, & | 9.3 (6.4–13.1) #, & |
| Age (years) | 54.3 ± 7.1# | 53.4 ± 5.6 & | 58.1 ± 8.7 #, & | 65.3 ± 10.9 #, & |
| BMI (kg/m2) | 23.2 ± 3.2 | 23.4 ± 3.4 | 24.1 ± 3.2 #, & | 24.6 ± 3.8 #, & |
| WC (cm) | 79.3 ± 10.0 | 79.3 ± 8.6 | 82.3 ± 9.1 #, & | 84.8 ± 9.4 #, & |
| SBP (mmHg) | 123.6 ± 15.3 | 123.0 ± 15.6 | 127.0 ± 16.0 #, & | 131.8 ± 17.1 #, & |
| DBP (mmHg) | 74.1 ± 9.1 | 73.8 ± 9.4 | 74.6 ± 9.5 | 74.6 ± 9.7 |
| Current smoking [n (%)] | 21 (2.8) # | 37 (0.9) & | 11 (1.1) & | 9 (2.0) # |
| Current drinking [n (%)] | 14 (2.0) # | 45 (1.1) & | 16 (1.7) | 6 (1.3) |
| TG (mmol/L) | 1.25 (0.92–1.78) # | 1.18 (0.87–1.69) & | 1.28 (0.97–1.84) # | 1.43 (0.99–1.99) #, & |
| TC (mmol/L) | 5.43 ± 1.24 # | 5.24 ± 1.27 & | 5.25 ± 1.27 & | 5.22 ± 1.26 & |
| HDL-C (mmol/L) | 1.42 ± 0.36 | 1.39 ± 0.37 | 1.36 ± 0.35 & | 1.28 ± 0.35 #, & |
| LDL-C (mmol/L) | 3.26 ± 0.97 # | 3.15 ± 0.98 & | 3.16 ± 0.96 | 3.15 ± 0.95 |
| FPG (mmol/L) | 5.35 (4.94–5.82) | 5.35 (4.95–5.80) | 5.50 (5.07–6.00) #, & | 5.60 (5.13–6.09) #, & |
| Fasting insulin (μIU/ml) | 7.10 (5.10–9.85) | 7.10 (5.20–9.70) | 7.80 (5.80–10.8) #, & | 8.20 (5.90–11.1) #, & |
| γ-GGT (U/L) | 18.0 (14.0–26.0) # | 17.0 (13.0–24.0) & | 19.0 (14.0–27.0) # | 19.0 (14.0–26.0) # |
| eGFR (ml/min per 1.73 m2) | 103.2 ± 23.0 # | 106.0 ± 23.2 & | 102.3 ± 20.8 # | 96.9 ± 22.2 #, & |
| Physical activity (MET-h/week) | 10.5 (0.0–36.0) | 24.8 (11.8–49.0) | 28.0 (12.0–49.0) | 21.0 (10.5–42.0) # |
| Prior history of CVD [n (%)] | 14 (1.7) | 81 (1.9) | 48 (4.9) #, & | 42 (9.7) #, & |
| High school or higher education [n (%)] | 463 (70.6) | 2902 (69.2) | 379 (39.2) #, & | 60 (13.3) #, & |
| Spontaneous abortion [n (%)] | 27 (3.3) # | 265 (6.3) & | 73 (7.4) & | 57 (12.5) #, & |
| Menopause [n (%)] | 139 (25.5) | 1111 (26.6) | 189 (19.5) #, & | 54 (11.8) #, & |
1. Data were means ± SD or medians (interquartile ranges) for skewed variables or numbers (proportions) for categorical variables; P-values were for the ANOVA or χ2 analyses across the groups
2. #P < 0.05 compared with participants with one live births (parity number equal to the 1 group); & P < 0.05 compared with participants with no live birth (parity number equal to the 0 group)
3. ACR albumin to creatinine ratio, BMI body mass index, WC waist circumference, SBP systolic blood pressure, DBP diastolic blood pressure, TG triglycerides, TC total cholesterol, HDL-C high-density lipoprotein cholesterol, LDL-C low-density lipoprotein cholesterol, FPG fasting plasma glucose, eGFR estimated glomerular filtration rate, γ-GGT γ-glutamyltransferase
Pearson’s correlation and stepwise regression analysis of determinants of ACR
| r | Standardized β | |||
|---|---|---|---|---|
| Age (years) | 0.11 | < 0.0001 | 0.10 | < 0.0001 |
| BMI (kg/m2) | 0.04 | 0.0009 | – | – |
| WC (cm) | 0.06 | < 0.0001 | – | – |
| SBP (mmHg) | 0.15 | < 0.0001 | 0.11 | < 0.0001 |
| DBP (mmHg) | 0.09 | < 0.0001 | – | – |
| Current smoking [n (%)] | 0.02 | 0.20 | – | – |
| Current drinking [n (%)] | 0.005 | 0.673 | – | – |
| TG (mmol/L) | 0.08 | < 0.0001 | 0.05 | 0.0003 |
| TC (mmol/L) | 0.02 | 0.129 | – | – |
| HDL-C (mmol/L) | −0.03 | 0.017 | 0.05 | 0.0017 |
| LDL-C (mmol/L) | 0.002 | 0.829 | – | – |
| FPG (mmol/L) | 0.10 | < 0.0001 | 0.07 | < 0.0001 |
| Fasting insulin (μIU/ml) | 0.05 | 0.0002 | – | – |
| γ-GGT (U/L) | 0.07 | < 0.0001 | – | – |
| eGFR (ml/min per 1.73 m2) | 0.05 | 0.0002 | 0.11 | < 0.0001 |
| Physical activity (MET-h/week) | −0.02 | 0.104 | −0.03 | 0.0390 |
| Prior history of CVD [n (%)] | −0.03 | 0.037 | – | – |
| High school or higher education [n (%)] | −0.05 | < 0.0001 | – | – |
| Spontaneous abortion [n (%)] | −0.005 | 0.664 | – | – |
| Menopause [n (%)] | −0.06 | < 0.0001 | – | – |
r, correlation coefficient; β, regression coefficient
The risk of prevalent low-grade albuminuria according to elevated parity degree
| Number of Parity | ||||
|---|---|---|---|---|
| 0 | 1 | 2 | ≥ 3 | |
| Low-grade albuminuria | ||||
| Model 1 | 1.07 (0.90–1.28) | 1 | 1.23 (1.05–1.44) | 1.72 (1.40–2.11) |
| Model 2 | 1.06 (0.89–1.26) | 1 | 1.14 (0.97–1.34) | 1.39 (1.11–1.75) |
| Model 3 | 1.03 (0.86–1.23) | 1 | 1.11 (0.94–1.31) | 1.33 (1.06–1.69) |
| Model 4 | 1.01 (0.83–1.22) | 1 | 1.13 (0.95–1.34) | 1.41 (1.09–1.81) |
Data are odds ratios (95% confidence interval). Participants without low-grade albuminuria are defined as 0 and with low-grade albuminuria as 1
Model 1 is unadjusted
Model 2 is adjusted for age
Model 3 is adjusted for age, SBP, TG, HDL-C, FPG, eGFR, and physical activity levels
Model 4 is adjusted for age, SBP, TG, HDL-C, FPG, eGFR, physical activity, education levels, and prior history of CVD
Fig. 1Multivariate logistic regression analyses of parity number with prevalent low-grade albuminuria
Fig. 2Risk of prevalent low-grade albuminuria with elevated parity degree in different subgroups